THE first malaria prevention product in 20 years has been approved for marketing in Australia by the Therapeutic Goods Administration (TGA).
Kodatef (tafenoquine) tablets from 60 Degrees Pharmaceuticals and Biocelect is suitable for the four million Australian travellers visiting maria-prone parts of the world each year.
Malaria remains widespread in many countries including Australia's near neighbours such as Papua New Guinea, Vanuatu, Solomon Islands and various South East Asian countries, while malaria drug resistance is a growing concern, the companies noted.
Kodatef kills malaria parasites in both the blood and liver stages.
Visit biocelect.com for more.
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Sep 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Sep 18
